Table of Contents Title of each class Trading symbol Name of exchange on which registered BioLife Solutions, Inc. Common Shares BLFS NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Rod de Greef - Chief Financial Officer Michael Rice - Chief Executive Officer Conference Call Participants Chris Lin - Cowen and Company Mason Carrico - Stephens Inc. Thomas Flaten - Lake Street Capital Markets, LLC Adheip Mally - Maxim Group Marc Wiesenberger - B. Riley Securities, Inc. Michael Ott - Oppenheimer & Co., Inc. Carl Byrnes - Northland Securities, Inc Operator Ladies and gentl ...

Table of Contents Title of each class Trading symbol Name of exchange on which registered BioLife Solutions, Inc. Common Shares BLFS NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File N ...

Biolife Solutions, Inc. (NASDAQ:BLFS) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Roderick de Greef - CFO, COO & Secretary Michael Rice - President, CEO & Director Conference Call Participants Jacob Johnson - Stephens Inc. Marc Wiesenberger - B. Riley FBR, Inc. Carl Byrnes - Northland Capital Markets Corey Deutsch - Analyst Operator Welcome to the BioLife Solutions Second Quarter 2020 Conference Call. My name is Rebecca, and I will be your operator for today's call. Opera ...

| --- | --- | --- | |----------------------------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | We enable cell and gene therapy success by providing class-defining bioproduction solutions. | | | | | | | AUGUST 2020 NASDAQ : BLFS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |---------------------------------------------------------------------------------------|-------------------------------------------------- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) DELAWARE 94-3076866 (State or other jurisd ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Roderick de Greef - Chief Financial Officer Mike Rice - President & Chief Executive Officer Conference Call Participants Paul Knight - Janney Montgomery Suraj Kalia - Oppenheimer Jacob Johnson - Stephens Blair Cohn - H.C. Wainwright Thomas Flaten - Lake Street Capital Marc Wiesenberger - B. Riley FBR Christopher Hillary - Roubaix Capital Carl Byrnes - Northland Capital Operator Ladies and gent ...

NASDAQ : BLFS Q4 & FY2019 Earnings Call March 11, 2020 BioLife Solutions Q4 & FY2019 Earnings Call : March 11, 2020 1 Disclaimer NASDAQ: BLFS Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company fol ...

NASDAQ : BLFS Investor Presentation March 2020 BioLife Solutions Investor Presentation : March 2020 1 Disclaimer NASDAQ: BLFS Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company following the compl ...